Concepedia

Jin‐Chen Yu

JY

Statistics

Publications

21

Citations

2.8K

H-Index

15

Active since

1991

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Millennium Engineering and Integration (United States)

Kyowa Kirin (Japan)

Harvard University

Jin‐Chen Yu is an author at National Cancer Institute specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1991–2023

21

Publications

21

The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathway

Omar A. Coso, M Chiariello, Jin‐Chen Yu et al. · Cell · 1995 · 1.6K citations · Full text

, , +8

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)

Louise Kelly, Jin‐Chen Yu, Christina Boulton et al. · Cancer Cell · 2002 · 307 citations · Full text

, , +9

Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD

Jennifer L. Rocnik, Rachel Okabe, Jin‐Chen Yu et al. · Blood · 2006 · 133 citations · Full text

Identification of Orally Active, Potent, and Selective 4-Piperazinylquinazolines as Antagonists of the Platelet-Derived Growth Factor Receptor Tyrosine Kinase Family

Anjali Pandey, Deborah L. Volkots, J. Seroogy et al. · Journal of Medicinal Chemistry · 2002 · 114 citations · Full text

Characterization of a Protein Kinase C-δ (PKC-δ) ATP Binding Mutant

Weiqun Li, Jin‐Chen Yu, Deug-Yong Shin et al. · Journal of Biological Chemistry · 1995 · 94 citations · Full text

1–5 of 21